发明授权
- 专利标题： Substituted chromanysulfonyl (thio) ureas, processing for their preparation and pharmaceutical uses thereof
- 专利标题（中）： 取代的色氨基磺酰（硫）脲，其制备及其制药用途
-
申请号： US760610申请日： 1996-12-04
-
公开(公告)号： US5811448A公开(公告)日： 1998-09-22
- 发明人: Heinrich Christian Englert , Uwe Gerlach , Dieter Mania , Wolfgang Linz , Heinz Gogelein , Erik Klaus , Peter Crause
- 申请人： Heinrich Christian Englert , Uwe Gerlach , Dieter Mania , Wolfgang Linz , Heinz Gogelein , Erik Klaus , Peter Crause
- 申请人地址： DEX Frankfurt am Main
- 专利权人： Hoechst Aktiengesellschaft
- 当前专利权人： Hoechst Aktiengesellschaft
- 当前专利权人地址： DEX Frankfurt am Main
- 优先权： DEX19546736.1 19951214
- 主分类号： C07D311/58
- IPC分类号： C07D311/58 ; A61K31/35 ; A61K31/352 ; A61K31/353 ; A61K31/40 ; A61K31/4015 ; A61K31/4025 ; A61K31/4412 ; A61K31/443 ; A61K31/445 ; A61P9/00 ; A61P9/06 ; A61P9/10 ; C07D311/64 ; C07D311/70 ; C07D405/12 ; C07D311/60 ; C07D407/12
摘要：
Substituted chromanylsulfonyl(thio)ureas, processes for their preparation, their use in pharmaceutical preparations, and pharmaceutical preparations comprising them Chromanylsulfonyl(thio)ureas of the formula I ##STR1## are useful pharmaceuticals for the treatment of cardiac arrhythmias and for the prevention of sudden heart death due to arrhythmia. They can be used as antiarrhythmics and are suitable for the prevention of sudden heart death, for the treatment of cardiac insufficiency and also heart failure as a result of the effects of shock.
公开/授权文献
- US5152532A Golf stroke training attachment 公开/授权日：1992-10-06